Search results for "slas europe 2018"
Selected Filters:
DeNovix becomes sponsor at Tufts Launchpad BioLabs
DeNovix has provided a CellDrop™ FL Automated Cell Counter and a DS-11 FX+ Spectrophotometer / Fluorometer for use by the facility’s resident companies
Fresh Produce Quality – Delaying the Inevitable?
SARS-CoV-2, influenza, and other seasonal viruses: Northern and Southern Hemisphere perspectives
Watch this on-demand webinar for expert insight on future healthcare strategies for seasonal respiratory viruses in a post-pandemic era
How biobanks are driving innovation in oncology: Watch on demand
Check out this free webinar to find out how biobanks are aiding the screening of cancers such as colorectal and breast cancer
New and Emerging Techniques in POPs Analysis
Dr Esteban Abad, Institute of Environmental Assessment and Water Research – Spanish Council for Scientific Research
Syrris Launches New Flow Chemistry Systems
Drug Monitoring and Metabolism Research: Highlights from Viapath’s Fourth Innovation Academy
Next generation innovations on drug monitoring and metabolism research
Yourgene Health launches IONA Care+ non-invasive prenatal testing service
Offers expectant parents fully comprehensive prenatal screening test for genetic conditions, including microdeletions
Thermo Fisher Scientific launches Detachable Dynabeads to enhance cell therapy development and production
T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing
Clinical trials under way testing treatment options for COVID-19
The scientific community is working at full speed to fight the severe acute respiratory syndrome
Eppendorf Celebrates Opening of New UK Headquarters
Nosopharm and Evotec Enter into Collaboration to Accelerate Development of Novel Antibiotics
New partnership to advance Nosopharm’s lead candidate to clinical stage
Revolutionary System Allows Diabetics to Check Glucose Levels Without Calibration or Routine Finger Sticks
First-of-its-kind product has driven significant reimbursement in key markets, due to exceptional clinical outcome data and proven accuracy






















